Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
dc.contributor.author | Lódi, Mária | |
dc.contributor.author | Priksz, Dániel | |
dc.contributor.author | Fülöp, Gábor Áron | |
dc.contributor.author | Bódi, Beáta | |
dc.contributor.author | Gyöngyösi, Alexandra | |
dc.contributor.author | Nagy, Lilla | |
dc.contributor.author | Kovács, Árpád | |
dc.contributor.author | Kertész, Attila Béla | |
dc.contributor.author | Kocsis, Judit | |
dc.contributor.author | Édes, István | |
dc.contributor.author | Csanádi, Zoltán | |
dc.contributor.author | Czuriga, István | |
dc.contributor.author | Kisvárday, Zoltán | |
dc.contributor.author | Juhász, Béla | |
dc.contributor.author | Lekli, István | |
dc.contributor.author | Bai, Péter | |
dc.contributor.author | Tóth, Attila | |
dc.contributor.author | Papp, Zoltán | |
dc.contributor.author | Czuriga, Dániel | |
dc.date.accessioned | 2019-07-26T08:59:01Z | |
dc.date.available | 2019-07-26T08:59:01Z | |
dc.date.issued | 2019 | |
dc.date.oa | 2019-07-26 | |
dc.date.pasync | 2023-09-08T23:07:16Z | |
dc.date.updated | 2022-08-10T00:30:13Z | |
dc.description.corrector | LB | |
dc.identifier.citation | Journal of Translational Medicine. -17 (2019), p. 229. -J. Transl. Med. - 1479-5876 | |
dc.identifier.doi | http://dx.doi.org/10.1186/s12967-019-1978-0 | |
dc.identifier.issn | 1479-5876 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM080058 | |
dc.identifier.scopus | 85069513474 | |
dc.identifier.uri | http://hdl.handle.net/2437/272549 | |
dc.identifier.url | https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-1978-0 | |
dc.identifier.wos | 000476538500001 | |
dc.language | eng | |
dc.rights.access | open access journal | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Elméleti orvostudományok | |
dc.tender | EFOP-3.6.2-16-2017-00006 | |
dc.tender | GINOP-2.3.2-15-2016-00043 | |
dc.tender | Egyéb ÚNKP-18-4-DE-49 | |
dc.tender | Egyéb ÚNKP-18-3-III-DE-387 | |
dc.title | Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nem elérhető
- Név:
- FILE_UP_1_Lódi - J Translational Med - 2019.pdf
- Méret:
- 4.06 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Kiadói változat